0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Original Article |

Effects of HTR1A C(−1019)G on Amygdala Reactivity and Trait Anxiety FREE

Eric Fakra, MD; Luke W. Hyde, MS; Adam Gorka, BS; Patrick M. Fisher, BS; Karen E. Muñoz, BS; Mark Kimak, BS; Indrani Halder, PhD; Robert E. Ferrell, PhD; Stephen B. Manuck, PhD; Ahmad R. Hariri, PhD
[+] Author Affiliations

Author Affiliations: CIC-UPCET, Hôpital de la Timone, Service Hospitalo–Universitaire de Psychiatrie, Hôpital Ste Marguerite, Marseille, France (Dr Fakra); and Departments of Psychiatry (Drs Fakra, Halder, Manuck, and Hariri), Psychology (Mssrs Hyde and Gorka, Ms Muñoz, and Drs Manuck and Hariri), and Human Genetics (Mr Kimak and Dr Ferrell), and Center for Neuroscience (Mr Fisher and Dr Hariri), University of Pittsburgh, Pittsburgh, Pennsylvania.


Arch Gen Psychiatry. 2009;66(1):33-40. doi:10.1001/archpsyc.66.1.33.
Text Size: A A A
Published online

Context  Serotonin 1A (5-hydroxytryptamine 1A [5-HT1A]) autoreceptors mediate negative feedback inhibition of serotonergic neurons and play a critical role in regulating serotonin signaling involved in shaping the functional response of major forebrain targets, such as the amygdala, supporting complex behavioral processes. A common functional variation (C[−1019]G) in the human 5-HT1A gene (HTR1A) represents 1 potential source of such interindividual variability. Both in vitro and in vivo, −1019G blocks transcriptional repression, leading to increased autoreceptor expression. Thus, −1019G may contribute to relatively decreased serotonin signaling at postsynaptic forebrain target sites via increased negative feedback.

Objectives  To evaluate the effects of HTR1A C(−1019)G on amygdala reactivity and to use path analyses to explore the impact of HTR1A-mediated variability in amygdala reactivity on individual differences in trait anxiety. We hypothesized that −1019G, which potentially results in decreased serotonin signaling, would be associated with relatively decreased amygdala reactivity and related trait anxiety.

Design  Imaging genetics in participants from an archival database.

Participants  Eighty-nine healthy adults.

Results  Consistent with prior findings, −1019G was associated with significantly decreased threat-related amygdala reactivity. Importantly, this effect was independent of that associated with another common functional polymorphism that affects serotonin signaling, 5-HTTLPR. While there were no direct genotype effects on trait anxiety, HTR1A C(−1019)G indirectly predicted 9.2% of interindividual variability in trait anxiety through its effects on amygdala reactivity.

Conclusions  Our findings further implicate relatively increased serotonin signaling, associated with a genetic variation that mediates increased 5-HT1A autoreceptors, in driving amygdala reactivity and trait anxiety. Moreover, they provide empirical documentation of the basic premise that genetic variation indirectly affects emergent behavioral processes related to psychiatric disease risk by biasing the response of underlying neural circuitries.

Figures in this Article

The amygdala, through its extensive interactions with other limbic and cortical regions, plays a central role in the generation of emotional behaviors.1 Moreover, abnormal amygdala function has been implicated in psychiatric disorders, such as depression and anxiety,2 often characterized by abnormal emotional responses. Converging preclinical and clinical evidence indicates that amygdala functioning is sensitive to the effects of central serotonin,3 whose principle forebrain innervation is provided by the midbrain dorsal raphe nucleus. Multiple mechanisms involving de novo biosynthesis, vesicular release, active reuptake, metabolic degradation, as well as both presynaptic and postsynaptic receptors contribute to the regulation of serotonin neurotransmission and its subsequent modulation of brain function.4 In general, component processes that affect the magnitude of signaling (eg, biosynthesis, reuptake, and autoregulation) rather than localized effects on target neurons (eg, postsynaptic receptors) represent key bottlenecks in serotonin regulation of neural circuit function. Crucial among these is activation of somatodendritic serotonin 1A (5-hydroxytryptamine 1A [5-HT1A]) autoreceptors, which mediate negative feedback on dorsal raphe nucleus neurons, resulting in decreased serotonin release at postsynaptic targets in the forebrain.5 Using a multimodal neuroimaging strategy, we previously reported that the density of 5-HT1A autoreceptors accounts for 30% to 44% of variability in amygdala reactivity in healthy adults,6 confirming the important role of 5-HT1A autoreceptors in modulating the activity of serotonergic target regions.

As a likely consequence of the impact of the 5-HT1A autoreceptor on serotonin release, variability in 5-HT1A autoreceptor function has been linked to personality traits and psychiatric illnesses.79 It has also been suggested that 5-HT1A autoreceptors constitute a critical pharmacotherapeutic target. One such example is the desensitization of these receptors after chronic administration of selective serotonin reuptake inhibitors,10 which may participate in correcting pathologically decreased serotonin neurotransmission11 and altered amygdala reactivity observed in patients with major depression.12 Given the critical role of 5-HT1A autoreceptors in regulating serotonin signaling and its resulting influence on the functioning of major brain targets, such as the amygdala, and complex behavioral processes, it is important to identify sources of emergent variability in 5-HT1A function.

A common sequence variation in the human 5-HT1A gene (HTR1A [OMIM 109760]) represents 1 potential source of such interindividual variability. Recently, a relatively common single nucleotide polymorphism in the promoter region of HTR1A, C(−1019)G, was demonstrated to affect transcriptional regulation of the gene through altered binding of the transcription factors human NUDR (nuclear DEAF-1–related protein)/DEAF-1 (deformed epidermal autoregulatory factor 1) and hairy/enhancer-of-split-5 (Hes5). Specifically, the −1019G allele abolishes repression of the promoter by NUDR/DEAF-1 and partially impairs Hes5-mediated repression and, as a consequence, is associated with increased HTR1A protein and binding.13 Consistent with this finding, in vivo human positron emission tomography has revealed increased 5-HT1A autoreceptor density in both healthy adults and patients with depression carrying the −1019G allele.14 However, a similar effect was not observed in an earlier positron emission tomography study.15 Regardless, the in vitro effects of the HTR1A −1019G allele and the more general association documented between increased 5-HT1A autoreceptor density and decreased amygdala reactivity4 suggest that this common functional genetic variation may contribute significantly to the emergence of interindividual variability in amygdala reactivity.

In the current study, we used imaging genetics, a strategy previously implemented to identify the neurobiological impact of common functional variation in other serotonin-related genes,1621 to evaluate the effects of the HTR1A C(−1019)G variant on amygdala reactivity in response to an archival functional magnetic resonance imaging (fMRI) challenge paradigm in 89 healthy adults. We hypothesized that compared with the HTR1A −1019C allele, the −1019G allele, which abolishes NUDR/DEAF-1 and impairs Hes5-mediated transcriptional repression leading to increased 5-HT1A autoreceptor density, would be associated with relatively lower amygdala reactivity, putatively reflecting increased negative feedback and consequently decreased serotonin signaling. In addition, because prior studies have linked individual differences in anxiety with amygdala function,2225 we used path analyses to explore the association between HTR1A-mediated variability in amygdala reactivity and individual differences in trait anxiety.

Our a priori focus on 5-HT1A autoreceptors and not postsynaptic 5-HT1A heteroreceptors is driven by 2 major findings. The first is our earlier discovery that 5-HT1A autoreceptors account for a greater proportion of variability in amygdala reactivity than local postsynaptic heteroreceptors.6 The second is recent in vitro data that illustrate cell-specific effects of the −1019G allele on transcriptional repression. Specifically, the −1019G allele leads to consistently increased expression of 5-HT1A autoreceptors but does not consistently alter and sometimes even decreases expression of postsynaptic receptors.26 This in vitro finding is supported by the in vivo study documenting increased density of autoreceptors but not postsynaptic cortical or limbic receptors in −1019G allele carriers.14 Collectively, these results suggest that 5-HT1A autoreceptors, not heteroreceptors, account for most of the 5-HT1A–mediated variability in amygdala reactivity and that the −1019G allele may specifically affect the regulated expression of 5-HT1A autoreceptors.

PARTICIPANTS

A total of 103 participants were recruited from the Adult Health and Behavior project, an archival database encompassing detailed measures of behavioral and biological traits among a community sample of 1379 nonpatient, middle-aged volunteers. Written informed consent according to the guidelines of the University of Pittsburgh's institutional review board was provided by all subjects before their participation in our neuroimaging subcomponent of the Adult Health and Behavior project. All participants included in our analyses were in good general health and free of the following: (1) medical diagnoses of cancer, stroke, diabetes requiring insulin treatment, chronic kidney or liver disease, or a lifetime history of psychotic symptoms; (2) use of psychotropic, glucocorticoid, or cardiovascular (eg, antihypertensive or antiarrhythmic) medication; (3) conditions that affect cerebral blood flow and metabolism (eg, hypertension); and (4) any current DSM-IV Axis I disorder as assessed by the nonpatient version of the Structured Clinical Interview for DSM-IV.27

Both the Adult Health and Behavior project and our smaller neuroimaging study have been developed for the explicit purpose of facilitating hypothesis-driven investigations of variables that possibly mediate interindividual variability in behavioral traits representing potential predictive markers of physical and mental health. In fact, combinations of neuroimaging, behavioral, and molecular genetics data from a number of our 103 participants (range, 31-89) have been used in several prior studies that examined biological pathways that mediate interindividual variability in behaviorally relevant brain function.2833 In the current study, overlapping HTR1A C(−1019)G genotype and threat-related amygdala reactivity data were available in 89 adults of European ancestry.

GENOTYPING

High–molecular weight DNA was isolated from EDTA-anticoagulated whole blood samples obtained from all participants using a salting-out procedure. Each sample was genotyped using polymerase chain reaction amplification and fluorescence polarization primers. Primers were designed to produce a 272–base pair (bp) fragment containing the HTR1A C(−1019)G single-nucleotide polymorphism (rs6295; primers available from the corresponding author upon request). Polymerase chain reaction was carried out for 35 cycles at an annealing temperature of 55°C in a reaction mixture containing 1.5-mM of Mg++. Resulting products were cleaned by 1.5 hours of incubation with ExoSAP (USB Corporation, Cleveland, Ohio). Genotyping of the C→G transversion was performed using the LJL AnalystHT (Molecular Devices, Sunnyvale, California). In addition to HTR1A C(−1019)G, 5-HTTLPR, MAOA 30-bp variable number of tandem repeats, and TPH2 G(−844)T were all genotyped using published protocols.16,20,28 All of these genotypes were scored by 2 independent readers using sequence-verified standards, and all call rates were greater than 95%. No additional polymorphisms in HTR1A were examined in our study.

We used the program STRUCTURE34 to evaluate the presence of genetic substructure in the sample. Fifteen ancestry informative markers (rs1022106, rs1335995, rs1439564, rs1502812, rs1860300, rs548146, rs705388, rs715994, rs720517, rs722743, rs730899, rs734204, rs9059966, rs1328994, and rs1485405), which are unlikely to be related to phenotypes of interest, were genotyped for this analysis. We ran STRUCTURE, assuming a model with admixture and correlated allele frequencies, individual α parameters, and independent FST for all subpopulations. We tested models with 1, 2, 3, and 4 subpopulations using a burn-in of 40 000 followed by 80 000 repetitions and compared the likelihoods of models fitting the data.

TRAIT ANXIETY ASSESSMENT

The Spielberger State-Trait Anxiety Inventory (STAI) is a self-report scale indexing the frequency with which individuals perceive encountered situations to be threatening and respond to such situations with subjective feelings of apprehension and tension.35 The STAI has been used extensively as a clinical and research instrument, including as an endophenotype in genetic association studies of candidate genes for neuropsychiatric disorders. This inventory consists of 2 scales, 1 assessing the general tendency to be anxious as a personality trait (STAI-Trait) and 1 measuring the degree of anxiety at a particular moment as a situation-dependent state (STAI-State). In this study, only the STAI-Trait version of the scale was administered, as trait scores better reflect dispositional anxiety.35

AMYGDALA REACTIVITY PARADIGM

The experimental fMRI paradigm consisted of 4 blocks of a face-processing task interleaved with 5 blocks of a sensorimotor control task.28,31,32,36 Participant performance (accuracy and reaction time) was monitored during all scans. During the face-processing task, participants viewed a trio of faces (expressing either anger or fear) and selected 1 of 2 faces (bottom) that was identical to a target face (top). Angry and fearful facial expressions can represent honest indicators of an ecologically valid threat, especially that related to conspecific challengers.37 Within this context, we interpret the amygdala activation elicited by our task as being threat-related. Each face-processing block consisted of 6 images, balanced for sex and target affect (angry or fearful), all of which were derived from a standard set of pictures of facial affect.38 During the sensorimotor control blocks, participants viewed a trio of simple geometric shapes (circles and vertical and horizontal ellipses) and selected 1 of 2 shapes (bottom) that were identical to a target shape (top). Each sensorimotor control block consisted of 6 different shape trios. All blocks were preceded by a brief instruction (“Match faces” or “Match shapes”) that lasted 2 seconds. In the face-processing blocks, each of the 6 face trios was presented for 4 seconds with a variable interstimulus interval of 2 to 6 seconds (mean, 4 seconds), for a total block length of 48 seconds. In the sensorimotor control blocks, each of the 6 shape trios was presented for 4 seconds with a fixed interstimulus interval of 2 seconds, for a total block length of 36 seconds. Total task time was 390 seconds. As we were not interested in neural networks associated with face-specific processing per se, but rather in eliciting a maximal amygdala response across all participants that we could then investigate for genotype effects, we chose not to use neutral faces as control stimuli because neutral faces can be subjectively experienced as affectively laden or ambiguous and thus engage the amygdala.22,39

BOLD fMRI ACQUISITION PARAMETERS

Each participant underwent scanning with a Siemens 3-T MAGNETOM Allegra (Siemens AG, Erlangen, Germany), which was developed specifically for advanced brain imaging applications and is characterized by increased T2* sensitivity and fast gradients (slew rate, 400 T/m/s), which minimize echo-spacing, thereby reducing echoplanar imaging geometric distortions and improving image quality. Blood oxygenation level–dependent (BOLD) functional images were acquired with a gradient-echo echoplanar imaging sequence (repetition time/echo time = 2000/25 milliseconds, field of view = 20 cm, matrix = 64 × 64), which covered 34 interleaved axial slices (3-mm slice thickness) aligned with the AC-PC plane and encompassing the entire cerebrum and most of the cerebellum. All scanning parameters were selected to optimize the quality of the BOLD signal while maintaining a sufficient number of slices to acquire whole-brain data. Before collecting fMRI data for each participant, we acquired a reference echoplanar imaging scan, which we visually inspected for artifacts (eg, ghosting) and good signal across the entire volume of acquisition, including the amygdala and ventral striatum. Additionally, an autoshimming procedure was conducted before the acquisition of BOLD data in each participant to minimize field inhomogeneities. The fMRI data from all 89 participants included in this study were cleared of such problems.

IMAGE PROCESSING AND ANALYSIS

Whole-brain image analysis was completed using the general linear model of SPM2 (Wellcome Department of Imaging Neuroscience, London, England). Images for each participant were realigned to the first volume in the time series to correct for head motion, spatially normalized into a standard stereotactic space (Montreal Neurological Institute template) using a 12-parameter affine model, and smoothed to minimize noise and residual difference in gyral anatomy with a gaussian filter set at 6 mm full-width at half-maximum. Voxelwise signal intensities were ratio-normalized to the whole-brain global mean. These preprocessed data sets were analyzed using second-level random-effects models that accounted for both scan-to-scan and participant-to-participant variability to determine task-specific regional responses.

After preprocessing, linear contrasts using canonical hemodynamic response functions were used to estimate condition-specific (ie, faces > shapes) BOLD activation for each individual and scan. These individual contrast images (ie, weighted sum of the beta images) were then used in second-level random-effects models to determine (1) mean condition-specific amygdala reactivity using 1-sample t tests, (2) main effects of HTR1A genotype on amygdala reactivity, and (3) the association between amygdala reactivity and STAI-Trait score using multiple regression (with 5-HTTLPR genotype as a covariate).

Our amygdala region of interest was constructed using the Talairach Daemon option of the WFU PickAtlas Tool, version 1.04 (Wake Forest University School of Medicine, Winston-Salem, North Carolina). Exploratory analyses of genotype effects were conducted in prefrontal regions, namely, the orbitofrontal cortex (Brodmann area [BA] 11), ventrolateral prefrontal cortex (BA 47), and dorsolateral prefrontal cortex (BA 9/44/45), exhibiting a main effect of task. These regions of interest were also defined using PickAtlas. A threshold at a voxel level of P < .05 was used for all analyses; analyses were false discovery rate–corrected for multiple comparisons within an inclusive mask of activations of interest; and an extent threshold of at least 10 contiguous voxels was also used. Because of our a priori, directionally specific hypotheses and our use of a rigorous random-effects model, these statistical thresholds effectively control for false-positives arising from multiple comparisons. Moreover, these statistical thresholds have recently been demonstrated to effectively limit false-positive associations in imaging genetics studies below 5% (0.2%-4.1%) and are, in fact, conservative.40 All neuroimaging data are reported using the coordinate system of Talairach and Tournoux.

ADDITIONAL DATA ANALYSES

A path model was used to examine the association between HTR1A genotype, amygdala reactivity, and trait anxiety. The cluster selected for the path analysis exhibited overlapping effects of genotype and trait anxiety and was identified by applying a mask created from the activation cluster correlated with trait anxiety to a subsequent regression analysis between amygdala reactivity and HTR1A genotype. This 2-step approach revealed a single activation cluster in the right amygdala exhibiting effects of both trait anxiety and genotype. Extracted activation values from the maximally activated voxel in the amygdala cluster showing overlapping effects of HTR1A genotype and STAI-Trait score were fitted using Mplus 4.0,41 which can test indirect effects through 2 complementary methods.42,43 First, Mplus 4.0 uses a product of coefficients test (also called the Sobel method42) to quantify the magnitude of the indirect effects with more power than some other widely used methods.44 Second, Mplus 4.0 constructs unbiased confidence intervals using bootstrapping methods, which do not assume normality of the distribution of indirect effects and can represent more powerful tests in smaller samples such as ours.43 While not the focus of our indirect effects analysis, path models generated in Mplus 4.0 can be tested for fit of the hypothesized model to the observed data. In our analyses, fit of a path model was considered acceptable if it had a nonsignificant χ2 fit statistic, a root-mean-square error of approximation (RMSEA) smaller than 0.08, and a standardized root-mean-square residual (SRMR) close to 0.45 Consistent with our general proposal that genetic effects on behavior are mediated through their effects on brain function,30,46 we predicted that the link between HTR1A genotype and trait anxiety would be mediated through amygdala reactivity (ie, HTR1A genotype predicts amygdala reactivity which, in turn, predicts trait anxiety). However, to explore possible direct links between HTR1A genotype and trait anxiety, we also modeled a direct path between these 2 variables. As this direct path was nonsignificant and the overall model fit decreased, this direct path was dropped from the final model.

SAMPLE DEMOGRAPHICS

The distribution of our observed genotype frequencies (Table) from the total cohort of 89 participants (C/C = 25, C/G = 36, G/G = 28 participants) was consistent with prior reports and did not deviate from Hardy-Weinberg equilibrium (χ2 = 0.38, P = .83). STRUCTURE analyses revealed no evidence of genetic substructure in our sample (log probability of data for k = 1, k = 2, k = 3, and k = 4 subpopulations in STRUCTURE were −1292.6, −1304.6, −1287.6, and −1296.3, respectively) and thus, no further adjustments were made to control for type I or type II errors attributable to genetic stratification. Moreover, HTR1A genotype groups did not differ (all χ2’s < 4.47, all P’s > .11) in the distribution of multiple additional functional serotonin-related polymorphisms (ie, 5-HTTLPR, MAOA 30-bp variable number of tandem repeats, and TPH2 G[−844]T) previously linked with variability in amygdala reactivity.16,20,28 This was true for either the 2- (C/C vs G carriers) or 3- (C/C, C/G, and G/G) genotype group classification schemes. Finally, genotype groups (using either the 2- or 3-genotype classification schemes) did not differ with respect to age, sex distribution, history of mood or anxiety disorders, task performance, or STAI-Trait score, which was normally distributed in our sample (Table). Although the distribution of 5-HTTLPR across HTR1A genotype groups was random, we nevertheless entered 5-HTTLPR genotype as a covariate in our neuroimaging data analysis because of its well-documented effect on amygdala reactivity,47 which may be mediated through altered 5-HT1A autoreceptor density.15

Table Graphic Jump LocationTable. Demographic and Performance Variables as a Function of HTR1A Genotype
HTR1A C(−1019)G EFFECTS ON AMYGDALA REACTIVITY

The main effects of task contrast (faces > shapes) were associated with significant bilateral amygdala reactivity across all participants. Regression analyses, corrected for effects of 5-HTTLPR, revealed a significant effect of HTR1A genotype on bilateral amygdala reactivity (Figure 1). This pattern was confirmed using analysis of covariance on the extracted maximal voxel amygdala activation values (right hemisphere: F2,86 = 3.66, P = .03; left hemisphere: F2,86 = 3.21, P = .045). Post hoc analyses revealed significant differences between individuals with the C/C genotype and those with either C/G (right hemisphere: t59 = 2.11, P = .04; left hemisphere: t57 = 2.06, P = .045) or G/G (right hemisphere: t47 = 2.59, P = .01; left hemisphere: t51 = 2.45, P = .02). There was no significant difference between C/G and G/G genotypes (right hemisphere: t62 = 0.95, P = .35; left hemisphere: t62 = 0.73, P = .47). As these results indicated that effects of C(−1019)G on amygdala reactivity were independent of −1019G allele load, all subsequent analyses were conducted using a simplified 2-genotype classification scheme (C/C homozygotes vs G carriers). Statistical parametric analyses using this 2-genotype classification confirmed the results of the analysis of covariance by identifying significant differences between C/C homozygotes and G carriers (right hemisphere: 36 voxels, z = 2.86, P < .05; left hemisphere: 27 voxels, z = 2.58, P < .05). Finally, exploratory analyses of HTR1A genotype effects on task-related activation in prefrontal regions of interest did not reveal any statistically significant effects.

Place holder to copy figure label and caption
Figure 1.

Single-subject mean (± standard error of the mean) activation values from the maximal voxel in a right amygdala cluster exhibiting an allele-load independent decrease in reactivity associated with HTR1A −1019G (x = 20 mm, y = −3 mm, z = −20 mm; cluster size = 11 voxels; z = 2.59, P < .05, false discovery rate (FDR)–corrected). Nearly identical effects were identified in a left amygdala cluster (x = −22 mm, y = −5 mm, z = −20 mm; cluster size = 20 voxels; z = 2.39, P < .05, FDR-corrected). AU indicates arbitrary units.

Graphic Jump Location
INDIRECT PREDICTION OF TRAIT ANXIETY THROUGH AMYGDALA REACTIVITY BY HTR1A C(−1019)G

Mean single-subject activation values from the maximal voxel in the right amygdala cluster exhibiting a correlation with both HTR1A genotype and STAI-Trait score (Figure 2A) were extracted for use in our path models. Analyses in Mplus 4.0 using these extracted values revealed no significant direct path between HTR1A genotype and STAI-Trait score in the model (B = −2.13, SE = 1.95, P > .25) and thus this path was dropped. In contrast, analyses in Mplus 4.0 revealed significant direct paths from HTR1A genotype to amygdala reactivity (B = 0.91, SE = 0.31, P < .01) and from amygdala reactivity to STAI-Trait score (B = 1.76, SE = 0.59, P < .01) (Figure 2B). Moreover, the indirect path from HTR1A genotype to STAI-Trait score through amygdala reactivity was significant (αβ = −1.60, SE = 0.73, P < .05). This model accounted for 9.2% of the variability in STAI-Trait scores, indicating that relatively decreased amygdala reactivity contributes to decreased trait anxiety in −1019G carriers and that the effect of HTR1A genotype on trait anxiety is through its effect on amygdala reactivity. The bootstrapped confidence interval for this estimate did not contain 0, further indicating a significant indirect effect. The proposed model also had an acceptable fit (χ2 = 1.35, ns, RMSEA = 0.06, SRMR = 0.05). In addition, the results were consistent across different models and extraction methods. The indirect effect was significant in the model containing the direct path from HTR1A genotype to STAI-Trait score (αβ = −1.41, SE = 0.70, P < .05), as well as when using a model containing the mean value extracted from the entire activation cluster rather than maximal voxel (αβ = −1.33, SE = 0.66, P < .05).

Place holder to copy figure label and caption
Figure 2.

A, Statistical parametric map illustrating the right amygdala cluster correlated with both HTR1A genotype and State-Trait Anxiety Inventory–Trait (STAI-Trait) scores (cluster size = 13 voxels; z = 2.86, P = .02, false discovery rate–corrected). Single-subject activation values from the maximal voxel in this cluster (x = 26, y = 1, z = −15) were entered into our path analyses. B, Path model showing indirect effects of HTR1A genotype on trait anxiety (STAI-Trait). Lines are labeled with unstandardized path coefficients and SEs in parentheses. Coefficients in bold represent values from the trimmed model, while italicized coefficients represent values from the full model with all paths included. Indirect effects of HTR1A genotype on trait anxiety were significant (αβ = −1.60, SE = 0.73, P < .05), while direct effects were nonsignificant and dropped from the model. e1 and e2 represent the residual variance not explained by model variables. *P < .01, †P < .05.

Graphic Jump Location

Consistent with our hypothesis, the HTR1A −1019G allele was associated with significantly decreased threat-related amygdala reactivity. This effect was independent of −1019G allele load, with both C/G and G/G genotypes exhibiting significantly reduced amygdala reactivity compared with C/C homozygotes as well as occult genetic stratification and other functional serotonin polymorphisms that affect amygdala reactivity, most notably 5-HTTLPR.16,20,28 Path models revealed no significant direct genotype effect on trait anxiety. The marginal nature of this association (P > .25) is consistent with previous studies in relatively small samples, which are likely insufficiently powered to detect direct effects between genotype and distal behavioral phenotypes. In contrast, HTR1A C(−1019)G and amygdala reactivity indirectly predicted a significant proportion (9.2%) of individual differences in trait anxiety through their respective indirect and direct paths.

Our observation of decreased amygdala reactivity in carriers of −1019G is specifically consistent with the in vitro13 and in vivo14 effects of this allele (ie, increased 5-HT1A autoreceptor expression associated with −1019G) and with our previous study demonstrating an inverse association between 5-HT1A autoreceptor density and amygdala reactivity.6 This pattern is more generally consistent with that reported for other common functional polymorphisms, namely the 5-HTTLPR short allele16,47 and MAOA low-activity alleles,20 which are also associated with relatively increased serotonin signaling. Collectively, these findings further implicate relatively increased serotonin signaling, regardless of the putative molecular mechanism, in driving amygdala reactivity and related behavioral processes, such as anxiety.3 Not only does this parallel the effects of increased serotonin in animal models,4852 but also the findings of a recent study demonstrating that acute blockade of serotonin reuptake with intravenous citalopram results in dose-dependent potentiation of human amygdala reactivity.53

Although this convergent data strongly implicate serotonin in driving amygdala reactivity, the detailed molecular mechanisms through which such effects are mediated are not fully understood. This effect likely reflects the complex coexpression of inhibitory and excitatory postsynaptic serotonin-receptor subtypes on both glutamatergic projection neurons and GABAergic interneurons of the amygdala.54 For example, serotonin-induced inhibition of glutamatergic activity in the lateral amygdala, which processes afferent sensory information, may be mediated through activation of excitatory serotonergic receptors on interneurons.55 However, agonism of excitatory 5-HT2A/2C and 5-HT3 postsynaptic receptors can increase the activity of both projection neurons and interneurons, and agonism of 5-HT1A postsynaptic receptors can decrease activity of interneurons.56 Furthermore, while excitatory postsynaptic 5-HT2A/2C receptors have been localized to both projection and interneurons57 and thus can both increase and decrease amygdala activity, a recent study suggests that 5-HT2A/2C receptors mediate the potentiation of amygdala-related conditioned fear responses following acute serotonin reuptake inhibition.48 The synaptic localization of serotonin receptors may also bias the net effect of serotonin on amygdala reactivity. In other forebrain target regions, inhibitory 5-HT1A receptors are localized within the synapse while excitatory 5-HT2A/2C receptors are extrasynaptic.5 Thus, a greater level of serotonin release (ie, volume transmission) may be necessary to evoke stimulation of these targets while a lesser level evokes inhibition. It is possible that the decreased serotonin release associated with −1019G is biased toward greater inhibition of amygdala target neurons (via preferential stimulation of synaptic 5-HT1A), reflected as decreased reactivity in BOLD fMRI. However, this putative mechanism is dependent on the appropriate expression of serotonin receptor subtypes, which remains largely unknown. Finally, although in vivo assays of 5-HT1A autoreceptor density indicate a functional effect of −1019G,14 our observed differences in amygdala reactivity may reflect early neurodevelopmental phenomena associated with altered serotonin signaling.58 In fact, only transgenic inactivation of the murine 5-HT1A gene during early development and not adulthood is associated with altered anxiety-like behaviors.59

Despite their consistency and convergence with those from in vitro and in vivo assays of −1019G effects on 5-HT1A autoreceptors, our current results differ from 2 studies examining the effects of HTR1A C(−1019)G on amygdala reactivity in patients with major depression21 and panic disorder.60 The −1019G allele, which is associated with relatively decreased amygdala reactivity in our sample of healthy adults, was associated with relatively increased amygdala reactivity in both patient populations. In the latter patient sample, however, this effect was limited to the left amygdala's responses to happy expressions; there was no difference in amygdala activation to fearful expressions. In addition, −1019G was associated with relatively decreased prefrontal activation to fearful expressions in these same patients. In contrast, we did not find a significant effect of HTR1A genotype on task-related prefrontal activation. The presence or absence of psychopathology across these samples represents an obvious potential factor driving these differing patterns. The findings in the much smaller samples of patients may reflect an interaction of HTR1A genotype with ongoing pathologic processes as well as other genetic and/or environmental factors that act in concert to produce psychopathology.61 The divergent effects reported in patients may also reflect additional variability in serotonin signaling following chronic exposure to psychotropic medications, especially selective serotonin reuptake inhibitors. In these studies, all patients with major depression21 and half the patients with a panic disorder60 were treated with selective serotonin reuptake inhibitors. Prospective studies in at-risk populations as well as in medication-naive patients at pretreatment and posttreatment are necessary to better characterize the association between the HTR1A C(−1019)G genotype, amygdala reactivity, the emergence of psychopathology, and therapeutic response.

Superficially, our current findings may appear contrary to reports that link −1019G with increased risk for mood and anxiety disorders62 as well as increased neuroticism and harm avoidance,63 all of which may be characterized by increased amygdala reactivity.2,23,64,65 As emphasized in a recent review, available association studies between −1019G and psychiatric liability are far from unequivocal, and studies to date have been generally underpowered.66 Furthermore, in contrast to the effects of −1019G on autoreceptor expression, several studies have documented decreased 5-HT1A autoreceptors in a range of mood and anxiety disorders.6772 Regardless, our existing data reflect only 1 factor involved in shaping both normal and pathologic emotional responses to the environment, namely limbic drive in the form of amygdala reactivity. We did not observe significant genotype effects on task-related prefrontal activation. However, the ability to examine neurobehavioral effects of serotonin signaling using BOLD fMRI is critically dependent on the challenge paradigms used. Our paradigm is focused on threat-related amygdala and extended corticolimbic reactivity associated with bottom-up limbic drive. It is possible that more complex, top-down (eg, emotion regulation) tasks may reveal effects of the −1019G allele extending to alterations in prefrontal regulatory circuitries whose dysfunction greatly contributes to and may characterize disorders of mood and emotion.73,74 Given the importance of serotonin in the development and function of corticolimbic circuitries,58 it is reasonable to speculate that decreased serotonin signaling associated with the −1019G allele also reduces prefrontal activation in response to amygdala drive (possibly via decreased stimulation of excitatory postsynaptic 5-HT2A receptors located on glutamatergic pyramidal neurons). This, in turn, may lead to insufficient regulation of the amygdala and the emergence of pathologic mood and emotion.

We believe that there is clearly a place for an alternative, neurobiologically informed view in the literature. In this regard, our current findings, which are remarkably consistent with the basic biology of serotonin as well as the C(−1019)G, provide an important mechanistic platform from which existing findings can be better appreciated and future, directionally specific hypothesis-driven association studies can be planned. Indeed, such staging has proved essential for advancing our understanding of many other genetic variants (eg, COMT val158met, BDNF val66met, 5-HTTLPR). Our simple, reliable, and robust paradigm has produced findings that constitute a necessary initial step toward understanding the influence of HTR1A C(−1019)G on more complex circuitries and processes. More importantly, our current findings represent an important step in imaging genetics research by providing empirical documentation for the basic premise that genetic variation indirectly affects emergent behavioral processes by biasing the response of underlying neural circuitries.30,46

Correspondence: Ahmad R. Hariri, PhD, Developmental Imaging Genetics Program, University of Pittsburgh, 3811 O’Hara St, Loeffler Bldg, Room 218, Pittsburgh, PA 15213 (haririar@upmc.edu).

Submitted for Publication: March 4, 2008; final revision received June 20, 2008; accepted July 29, 2008.

Financial Disclosure: None reported.

Funding/Support: This study was supported by grants HL040962 (Dr Manuck) and MH072837 (Dr Hariri) from the National Institutes of Health, as well as a NARSAD Young Investigator Award (Dr Hariri). Mr Hyde is supported by grant GM081760 from the predoctoral Training Program in Behavioral Brain Research. Mr Fisher is supported by grant DA023420 from the predoctoral Multimodal Neuroimaging Training Program. Dr Halder is supported by a Pittsburgh Mind Body Center postdoctoral fellowship. Mssrs Hyde and Fisher and Ms Muñoz are also supported by the University of Pittsburgh Center for the Neural Basis of Cognition.

Additional Contributions: Sarah M. Brown, BS, assisted with fMRI data collection and analyses.

LeDoux  JE Emotion circuits in the brain. Annu Rev Neurosci 2000;23155- 184
PubMed
Phillips  MLDrevets  WCRauch  SLLane  R Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003;54 (5) 515- 528
PubMed
Hariri  ARHolmes  A Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10 (4) 182- 191
PubMed
Barnes  NMSharp  T A review of central 5-HT receptors and their function. Neuropharmacology 1999;38 (8) 1083- 1152
PubMed
Sharp  TBoothman  LRaley  JQueree  P Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 2007;28 (12) 629- 636
PubMed
Fisher  PMMeltzer  CCZiolko  SKPrice  JCMoses-Kolko  ELBerga  SLHariri  AR Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity [erratum published in Nat Neurosci. 2007;10(2):263. Moses-Kolko EL (added); Berga SL (added)]. Nat Neurosci 2006;9 (11) 1362- 1363
PubMed
Cowen  PJPower  ACWare  CJAnderson  IM 5-HT1A receptor sensitivity in major depression: a neuroendocrine study with buspirone. Br J Psychiatry 1994;164 (3) 372- 379
PubMed
Hansenne  MPitchot  WPinto  EReggers  JScantamburlo  GFuchs  SPirard  SAnsseau  M 5-HT1A dysfunction in borderline personality disorder. Psychol Med 2002;32 (5) 935- 941
PubMed
Lesch  KPGutknecht  L Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int J Neuropsychopharmacol 2004;7 (4) 381- 385
PubMed
Blier  Pde Montigny  C Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999;21 (2) ((suppl)) 91S- 98S
PubMed
Artigas  FBel  NCasanovas  JMRomero  L Adaptative changes of the serotonergic system after antidepressant treatments. Adv Exp Med Biol 1996;39851- 59
PubMed
Harmer  CJMackay  CEReid  CBCowen  PJGoodwin  GM Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59 (9) 816- 820
PubMed
Lemonde  STurecki  GBakish  DDu  LHrdina  PDBown  CDSequeira  AKushwaha  NMorris  SJBasak  AOu  XMAlbert  PR Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23 (25) 8788- 8799
PubMed
Parsey  RVOquendo  MAOgden  RTOlvet  DMSimpson  NHuang  YYVan Heertum  RLArango  VMann  JJ Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006;59 (2) 106- 113
PubMed
David  SPMurthy  NVRabiner  EAMunafo  MRJohnstone  ECJacob  RWalton  RTGrasby  PM A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005;25 (10) 2586- 2590
PubMed
Hariri  ARMattay  VSTessitore  AKolachana  BFera  FGoldman  DEgan  MFWeinberger  DR Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297 (5580) 400- 403
PubMed
Bertolino  AArciero  GRubino  VLatorre  VDe Candia  MMazzola  VBlasi  GCaforio  GHariri  AKolachana  BNardini  MWeinberger  DRScarabino  T Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style. Biol Psychiatry 2005;57 (12) 1517- 1525
PubMed
Heinz  ABraus  DFSmolka  MNWrase  JPuls  IHermann  DKlein  SGrusser  SMFlor  HSchumann  GMann  KBuchel  C Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005;8 (1) 20- 21
PubMed
Pezawas  LMeyer-Lindenberg  ADrabant  EMVerchinski  BAMunoz  KEKolachana  BSEgan  MFMattay  VSHariri  ARWeinberger  DR 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005;8 (6) 828- 834
PubMed
Meyer-Lindenberg  ABuckholtz  JWKolachana  BHariri  ARPezawas  LBlasi  GWabnitz  AHonea  RVerchinski  BCallicott  JHEgan  MMattay  VWeinberger  DR Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A 2006;103 (16) 6269- 6274
PubMed
Dannlowski  UOhrmann  PBauer  JKugel  HBaune  BTHohoff  CKersting  AArolt  VHeindel  WDeckert  JSuslow  T Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 2007;6 (7) 672- 676
PubMed
Schwartz  CEWright  CIShin  LMKagan  JRauch  SL Inhibited and uninhibited infants “grown up”: adult amygdalar response to novelty. Science 2003;300 (5627) 1952- 1953
PubMed
Somerville  LHKim  HJohnstone  TAlexander  ALWhalen  PJ Human amygdala responses during presentation of happy and neutral faces: correlations with state anxiety. Biol Psychiatry 2004;55 (9) 897- 903
PubMed
Stein  MBGoldin  PRSareen  JZorrilla  LTBrown  GG Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002;59 (11) 1027- 1034
PubMed
Thomas  KMDrevets  WCDahl  RERyan  NDBirmaher  BEccard  CHAxelson  DWhalen  PJCasey  BJ Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001;58 (11) 1057- 1063
PubMed
Czesak  MLemonde  SPeterson  EARogaeva  AAlbert  PR Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 2006;26 (6) 1864- 1871
PubMed
First  MBSpitzer  RLGibbon  MWilliams  JBM Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition.  New York, NY New York State Psychiatric Institute, Biometrics Research Department1996;
Brown  SMPeet  EManuck  SBWilliamson  DEDahl  REFerrell  REHariri  AR A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 2005;10 (9) 884- 888, 805
PubMed
Forbes  EEBrown  SMKimak  MFerrell  REManuck  SBHariri  AR Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 2007;
PubMed
Hariri  ARDrabant  EMWeinberger  DR Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 2006;59 (10) 888- 897
PubMed
Brown  SMManuck  SBFlory  JDHariri  AR Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006;6 (2) 239- 245
PubMed
Neumann  SABrown  SMFerrell  REFlory  JDManuck  SBHariri  AR Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function. Biol Psychiatry 2006;60 (10) 1155- 1162
PubMed
Gianaros  PJHorenstein  JACohen  SMatthews  KABrown  SMFlory  JDCritchley  HDManuck  SBHariri  AR Perigenual anterior cingulate morphology covaries with perceived social standing. Soc Cogn Affect Neurosci 2007;2 (3) 161- 173
PubMed
Falush  DStephens  MPritchard  JK Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164 (4) 1567- 1587
PubMed
Spielberger  CD State-trait anger expression inventory.  Odessa, FL Psychological Assessment Resources, Inc1991;
Manuck  SBBrown  SMForbes  EEHariri  AR Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 2007;164 (10) 1613- 1614
PubMed
Darwin  CEkman  P The Expression of the Emotions in Man and Animals. 3rd ed. New York, NY Oxford University Press1998;
Ekman  PFriesen  WV Pictures of Facial Affect.  Palo Alto, CA Consulting Psychologists Press1976;
Wright  CIMartis  BSchwartz  CEShin  LMFischer  HHMcMullin  KRauch  SL Novelty responses and differential effects of order in the amygdala, substantia innominata, and inferior temporal cortex. Neuroimage 2003;18 (3) 660- 669
PubMed
Meyer-Lindenberg  ANicodemus  KKEgan  MFCallicott  JHMattay  VWeinberger  DR False positives in imaging genetics. Neuroimage 2008;40 (2) 655- 661
PubMed
Muthén  LKMuthén  BO Mplus User's Guide. 4th ed. Los Angeles, CA Mplus2004;
MacKinnon  DPLockwood  CMHoffman  JMWest  SGSheets  V A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002;7 (1) 83- 104
PubMed
Dearing  EHamilton  LC Contemporary advances and classic advice for analyzing mediating and moderating variables. Monogr Soc Res Child Dev 2006;71 (3) 88- 104
Baron  RMKenny  DA The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51 (6) 1173- 1182
PubMed
Kline  RB Principles and Practice of Structural Equation Modeling.  New York, NY Guilford1988;
Hariri  ARWeinberger  DR Imaging genomics. Br Med Bull 2003;65259- 270
PubMed
Munafò  MRBrown  SMHariri  AR Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis [published online ahead of print October 22, 2007]. Biol Psychiatry 2008;63 (9) 852- 857
PubMed
Burghardt  NSBush  DEAMcEwen  BSLeDoux  JE Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist [published online ahead of print May 23, 2007]. Biol Psychiatry 2007;62 (10) 1111- 1118
PubMed
Burghardt  NSSullivan  GMMcEwen  BSGorman  JMLeDoux  JE The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004;55 (12) 1171- 1178
PubMed
Maier  SFWatkins  LR Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 2005;29 (4-5) 829- 841
PubMed
Amat  JTamblyn  JPPaul  EDBland  STAmat  PFoster  ACWatkins  LRMaier  SF Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 2004;129 (3) 509- 519
PubMed
Amat  JMatus-Amat  PWatkins  LRMaier  SF Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Res 1998;812 (1-2) 113- 120
PubMed
Bigos  KLPollock  BGAizenstein  HFisher  PMBies  RRHariri  AR Acute 5-HT reuptake blockade potentiates human amygdala reactivity [published online ahead of print May 7, 2008]. Neuropsychopharmacology
PubMed10.1038/npp.2008.52
Holmes  A Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease [published online ahead of print March 26, 2008]. Neurosci Biobehav Rev 2008;32 (7) 1293- 1314
PubMed10.1016/j.neubiorev.2008.03.006
Stutzmann  GELeDoux  JE GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 1999;19 (11) RC8
PubMed
Stein  CDavidowa  HAlbrecht  D 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse 2000;38 (3) 328- 337
PubMed
McDonald  AJMascagni  F Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience 2007;146 (1) 306- 320
PubMed
Gaspar  P Genetic models to understand how serotonin acts during development. J Soc Biol 2004;198 (1) 18- 21
PubMed
Gross  CZhuang  XStark  KRamboz  SOosting  RKirby  LSantarelli  LBeck  SHen  R Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002;416 (6879) 396- 400
PubMed
Domschke  KBraun  MOhrmann  PSuslow  TKugel  HBauer  JHohoff  CKersting  AEngelien  AArolt  VHeindel  WDeckert  J Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 2006;9 (3) 349- 355
PubMed
Caspi  AMoffitt  TE Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006;7 (7) 583- 590
PubMed
Albert  PRLemonde  S 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004;10 (6) 575- 593
PubMed
Strobel  AGutknecht  LRothe  CReif  AMossner  RZeng  YBrocke  BLesch  KP Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm 2003;110 (12) 1445- 1453
PubMed
Canli  TZhao  ZDesmond  JEKang  EGross  JGabrieli  JD An fMRI study of personality influences on brain reactivity to emotional stimuli. Behav Neurosci 2001;115 (1) 33- 42
PubMed
Haas  BWOmura  KConstable  RTCanli  T Emotional conflict and neuroticism: personality-dependent activation in the amygdala and subgenual anterior cingulate. Behav Neurosci 2007;121 (2) 249- 256
PubMed
Drago  ARonchi  DDSerretti  A 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Int J Neuropsychopharmacol 2008;11 (5) 701- 721
PubMed
Arango  VUnderwood  MDBoldrini  MTamir  HKassir  SAHsiung  SChen  JJMann  JJ Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25 (6) 892- 903
PubMed
Boldrini  MUnderwood  MDMann  JJArango  V Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 2008;42 (6) 433- 442
PubMed
Drevets  WCFrank  EPrice  JCKupfer  DJHolt  DGreer  PJHuang  YGautier  CMathis  C PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999;46 (10) 1375- 1387
PubMed
Hirvonen  JKarlsson  HKajander  JLepola  AMarkkula  JRasi-Hakala  HNagren  KSalminen  JKHietala  J Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008;11 (4) 465- 476
PubMed
Lanzenberger  RRMitterhauser  MSpindelegger  CWadsak  WKlein  NMien  LKHolik  AAttarbaschi  TMossaheb  NSacher  JGeiss-Granadia  TKletter  KKasper  STauscher  J Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007;61 (9) 1081- 1089
PubMed
Neumeister  ABain  ENugent  ACCarson  REBonne  OLuckenbaugh  DAEckelman  WHerscovitch  PCharney  DSDrevets  WC Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004;24 (3) 589- 591
PubMed
Mayberg  HS Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65193- 207
PubMed
Ressler  KJMayberg  HS Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007;10 (9) 1116- 1124
PubMed

Figures

Place holder to copy figure label and caption
Figure 1.

Single-subject mean (± standard error of the mean) activation values from the maximal voxel in a right amygdala cluster exhibiting an allele-load independent decrease in reactivity associated with HTR1A −1019G (x = 20 mm, y = −3 mm, z = −20 mm; cluster size = 11 voxels; z = 2.59, P < .05, false discovery rate (FDR)–corrected). Nearly identical effects were identified in a left amygdala cluster (x = −22 mm, y = −5 mm, z = −20 mm; cluster size = 20 voxels; z = 2.39, P < .05, FDR-corrected). AU indicates arbitrary units.

Graphic Jump Location
Place holder to copy figure label and caption
Figure 2.

A, Statistical parametric map illustrating the right amygdala cluster correlated with both HTR1A genotype and State-Trait Anxiety Inventory–Trait (STAI-Trait) scores (cluster size = 13 voxels; z = 2.86, P = .02, false discovery rate–corrected). Single-subject activation values from the maximal voxel in this cluster (x = 26, y = 1, z = −15) were entered into our path analyses. B, Path model showing indirect effects of HTR1A genotype on trait anxiety (STAI-Trait). Lines are labeled with unstandardized path coefficients and SEs in parentheses. Coefficients in bold represent values from the trimmed model, while italicized coefficients represent values from the full model with all paths included. Indirect effects of HTR1A genotype on trait anxiety were significant (αβ = −1.60, SE = 0.73, P < .05), while direct effects were nonsignificant and dropped from the model. e1 and e2 represent the residual variance not explained by model variables. *P < .01, †P < .05.

Graphic Jump Location

Tables

Table Graphic Jump LocationTable. Demographic and Performance Variables as a Function of HTR1A Genotype

References

LeDoux  JE Emotion circuits in the brain. Annu Rev Neurosci 2000;23155- 184
PubMed
Phillips  MLDrevets  WCRauch  SLLane  R Neurobiology of emotion perception II: implications for major psychiatric disorders. Biol Psychiatry 2003;54 (5) 515- 528
PubMed
Hariri  ARHolmes  A Genetics of emotional regulation: the role of the serotonin transporter in neural function. Trends Cogn Sci 2006;10 (4) 182- 191
PubMed
Barnes  NMSharp  T A review of central 5-HT receptors and their function. Neuropharmacology 1999;38 (8) 1083- 1152
PubMed
Sharp  TBoothman  LRaley  JQueree  P Important messages in the ‘post’: recent discoveries in 5-HT neurone feedback control. Trends Pharmacol Sci 2007;28 (12) 629- 636
PubMed
Fisher  PMMeltzer  CCZiolko  SKPrice  JCMoses-Kolko  ELBerga  SLHariri  AR Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity [erratum published in Nat Neurosci. 2007;10(2):263. Moses-Kolko EL (added); Berga SL (added)]. Nat Neurosci 2006;9 (11) 1362- 1363
PubMed
Cowen  PJPower  ACWare  CJAnderson  IM 5-HT1A receptor sensitivity in major depression: a neuroendocrine study with buspirone. Br J Psychiatry 1994;164 (3) 372- 379
PubMed
Hansenne  MPitchot  WPinto  EReggers  JScantamburlo  GFuchs  SPirard  SAnsseau  M 5-HT1A dysfunction in borderline personality disorder. Psychol Med 2002;32 (5) 935- 941
PubMed
Lesch  KPGutknecht  L Focus on The 5-HT1A receptor: emerging role of a gene regulatory variant in psychopathology and pharmacogenetics. Int J Neuropsychopharmacol 2004;7 (4) 381- 385
PubMed
Blier  Pde Montigny  C Serotonin and drug-induced therapeutic responses in major depression, obsessive-compulsive and panic disorders. Neuropsychopharmacology 1999;21 (2) ((suppl)) 91S- 98S
PubMed
Artigas  FBel  NCasanovas  JMRomero  L Adaptative changes of the serotonergic system after antidepressant treatments. Adv Exp Med Biol 1996;39851- 59
PubMed
Harmer  CJMackay  CEReid  CBCowen  PJGoodwin  GM Antidepressant drug treatment modifies the neural processing of nonconscious threat cues. Biol Psychiatry 2006;59 (9) 816- 820
PubMed
Lemonde  STurecki  GBakish  DDu  LHrdina  PDBown  CDSequeira  AKushwaha  NMorris  SJBasak  AOu  XMAlbert  PR Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003;23 (25) 8788- 8799
PubMed
Parsey  RVOquendo  MAOgden  RTOlvet  DMSimpson  NHuang  YYVan Heertum  RLArango  VMann  JJ Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study. Biol Psychiatry 2006;59 (2) 106- 113
PubMed
David  SPMurthy  NVRabiner  EAMunafo  MRJohnstone  ECJacob  RWalton  RTGrasby  PM A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J Neurosci 2005;25 (10) 2586- 2590
PubMed
Hariri  ARMattay  VSTessitore  AKolachana  BFera  FGoldman  DEgan  MFWeinberger  DR Serotonin transporter genetic variation and the response of the human amygdala. Science 2002;297 (5580) 400- 403
PubMed
Bertolino  AArciero  GRubino  VLatorre  VDe Candia  MMazzola  VBlasi  GCaforio  GHariri  AKolachana  BNardini  MWeinberger  DRScarabino  T Variation of human amygdala response during threatening stimuli as a function of 5′HTTLPR genotype and personality style. Biol Psychiatry 2005;57 (12) 1517- 1525
PubMed
Heinz  ABraus  DFSmolka  MNWrase  JPuls  IHermann  DKlein  SGrusser  SMFlor  HSchumann  GMann  KBuchel  C Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat Neurosci 2005;8 (1) 20- 21
PubMed
Pezawas  LMeyer-Lindenberg  ADrabant  EMVerchinski  BAMunoz  KEKolachana  BSEgan  MFMattay  VSHariri  ARWeinberger  DR 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005;8 (6) 828- 834
PubMed
Meyer-Lindenberg  ABuckholtz  JWKolachana  BHariri  ARPezawas  LBlasi  GWabnitz  AHonea  RVerchinski  BCallicott  JHEgan  MMattay  VWeinberger  DR Neural mechanisms of genetic risk for impulsivity and violence in humans. Proc Natl Acad Sci U S A 2006;103 (16) 6269- 6274
PubMed
Dannlowski  UOhrmann  PBauer  JKugel  HBaune  BTHohoff  CKersting  AArolt  VHeindel  WDeckert  JSuslow  T Serotonergic genes modulate amygdala activity in major depression. Genes Brain Behav 2007;6 (7) 672- 676
PubMed
Schwartz  CEWright  CIShin  LMKagan  JRauch  SL Inhibited and uninhibited infants “grown up”: adult amygdalar response to novelty. Science 2003;300 (5627) 1952- 1953
PubMed
Somerville  LHKim  HJohnstone  TAlexander  ALWhalen  PJ Human amygdala responses during presentation of happy and neutral faces: correlations with state anxiety. Biol Psychiatry 2004;55 (9) 897- 903
PubMed
Stein  MBGoldin  PRSareen  JZorrilla  LTBrown  GG Increased amygdala activation to angry and contemptuous faces in generalized social phobia. Arch Gen Psychiatry 2002;59 (11) 1027- 1034
PubMed
Thomas  KMDrevets  WCDahl  RERyan  NDBirmaher  BEccard  CHAxelson  DWhalen  PJCasey  BJ Amygdala response to fearful faces in anxious and depressed children. Arch Gen Psychiatry 2001;58 (11) 1057- 1063
PubMed
Czesak  MLemonde  SPeterson  EARogaeva  AAlbert  PR Cell-specific repressor or enhancer activities of Deaf-1 at a serotonin 1A receptor gene polymorphism. J Neurosci 2006;26 (6) 1864- 1871
PubMed
First  MBSpitzer  RLGibbon  MWilliams  JBM Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition.  New York, NY New York State Psychiatric Institute, Biometrics Research Department1996;
Brown  SMPeet  EManuck  SBWilliamson  DEDahl  REFerrell  REHariri  AR A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol Psychiatry 2005;10 (9) 884- 888, 805
PubMed
Forbes  EEBrown  SMKimak  MFerrell  REManuck  SBHariri  AR Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 2007;
PubMed
Hariri  ARDrabant  EMWeinberger  DR Imaging genetics: perspectives from studies of genetically driven variation in serotonin function and corticolimbic affective processing. Biol Psychiatry 2006;59 (10) 888- 897
PubMed
Brown  SMManuck  SBFlory  JDHariri  AR Neural basis of individual differences in impulsivity: contributions of corticolimbic circuits for behavioral arousal and control. Emotion 2006;6 (2) 239- 245
PubMed
Neumann  SABrown  SMFerrell  REFlory  JDManuck  SBHariri  AR Human choline transporter gene variation is associated with corticolimbic reactivity and autonomic-cholinergic function. Biol Psychiatry 2006;60 (10) 1155- 1162
PubMed
Gianaros  PJHorenstein  JACohen  SMatthews  KABrown  SMFlory  JDCritchley  HDManuck  SBHariri  AR Perigenual anterior cingulate morphology covaries with perceived social standing. Soc Cogn Affect Neurosci 2007;2 (3) 161- 173
PubMed
Falush  DStephens  MPritchard  JK Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003;164 (4) 1567- 1587
PubMed
Spielberger  CD State-trait anger expression inventory.  Odessa, FL Psychological Assessment Resources, Inc1991;
Manuck  SBBrown  SMForbes  EEHariri  AR Temporal stability of individual differences in amygdala reactivity. Am J Psychiatry 2007;164 (10) 1613- 1614
PubMed
Darwin  CEkman  P The Expression of the Emotions in Man and Animals. 3rd ed. New York, NY Oxford University Press1998;
Ekman  PFriesen  WV Pictures of Facial Affect.  Palo Alto, CA Consulting Psychologists Press1976;
Wright  CIMartis  BSchwartz  CEShin  LMFischer  HHMcMullin  KRauch  SL Novelty responses and differential effects of order in the amygdala, substantia innominata, and inferior temporal cortex. Neuroimage 2003;18 (3) 660- 669
PubMed
Meyer-Lindenberg  ANicodemus  KKEgan  MFCallicott  JHMattay  VWeinberger  DR False positives in imaging genetics. Neuroimage 2008;40 (2) 655- 661
PubMed
Muthén  LKMuthén  BO Mplus User's Guide. 4th ed. Los Angeles, CA Mplus2004;
MacKinnon  DPLockwood  CMHoffman  JMWest  SGSheets  V A comparison of methods to test mediation and other intervening variable effects. Psychol Methods 2002;7 (1) 83- 104
PubMed
Dearing  EHamilton  LC Contemporary advances and classic advice for analyzing mediating and moderating variables. Monogr Soc Res Child Dev 2006;71 (3) 88- 104
Baron  RMKenny  DA The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51 (6) 1173- 1182
PubMed
Kline  RB Principles and Practice of Structural Equation Modeling.  New York, NY Guilford1988;
Hariri  ARWeinberger  DR Imaging genomics. Br Med Bull 2003;65259- 270
PubMed
Munafò  MRBrown  SMHariri  AR Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis [published online ahead of print October 22, 2007]. Biol Psychiatry 2008;63 (9) 852- 857
PubMed
Burghardt  NSBush  DEAMcEwen  BSLeDoux  JE Acute selective serotonin reuptake inhibitors increase conditioned fear expression: blockade with a 5-HT(2C) receptor antagonist [published online ahead of print May 23, 2007]. Biol Psychiatry 2007;62 (10) 1111- 1118
PubMed
Burghardt  NSSullivan  GMMcEwen  BSGorman  JMLeDoux  JE The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptine. Biol Psychiatry 2004;55 (12) 1171- 1178
PubMed
Maier  SFWatkins  LR Stressor controllability and learned helplessness: the roles of the dorsal raphe nucleus, serotonin, and corticotropin-releasing factor. Neurosci Biobehav Rev 2005;29 (4-5) 829- 841
PubMed
Amat  JTamblyn  JPPaul  EDBland  STAmat  PFoster  ACWatkins  LRMaier  SF Microinjection of urocortin 2 into the dorsal raphe nucleus activates serotonergic neurons and increases extracellular serotonin in the basolateral amygdala. Neuroscience 2004;129 (3) 509- 519
PubMed
Amat  JMatus-Amat  PWatkins  LRMaier  SF Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Res 1998;812 (1-2) 113- 120
PubMed
Bigos  KLPollock  BGAizenstein  HFisher  PMBies  RRHariri  AR Acute 5-HT reuptake blockade potentiates human amygdala reactivity [published online ahead of print May 7, 2008]. Neuropsychopharmacology
PubMed10.1038/npp.2008.52
Holmes  A Genetic variation in cortico-amygdala serotonin function and risk for stress-related disease [published online ahead of print March 26, 2008]. Neurosci Biobehav Rev 2008;32 (7) 1293- 1314
PubMed10.1016/j.neubiorev.2008.03.006
Stutzmann  GELeDoux  JE GABAergic antagonists block the inhibitory effects of serotonin in the lateral amygdala: a mechanism for modulation of sensory inputs related to fear conditioning. J Neurosci 1999;19 (11) RC8
PubMed
Stein  CDavidowa  HAlbrecht  D 5-HT(1A) receptor-mediated inhibition and 5-HT(2) as well as 5-HT(3) receptor-mediated excitation in different subdivisions of the rat amygdala. Synapse 2000;38 (3) 328- 337
PubMed
McDonald  AJMascagni  F Neuronal localization of 5-HT type 2A receptor immunoreactivity in the rat basolateral amygdala. Neuroscience 2007;146 (1) 306- 320
PubMed
Gaspar  P Genetic models to understand how serotonin acts during development. J Soc Biol 2004;198 (1) 18- 21
PubMed
Gross  CZhuang  XStark  KRamboz  SOosting  RKirby  LSantarelli  LBeck  SHen  R Serotonin1A receptor acts during development to establish normal anxiety-like behaviour in the adult. Nature 2002;416 (6879) 396- 400
PubMed
Domschke  KBraun  MOhrmann  PSuslow  TKugel  HBauer  JHohoff  CKersting  AEngelien  AArolt  VHeindel  WDeckert  J Association of the functional -1019C/G 5-HT1A polymorphism with prefrontal cortex and amygdala activation measured with 3 T fMRI in panic disorder. Int J Neuropsychopharmacol 2006;9 (3) 349- 355
PubMed
Caspi  AMoffitt  TE Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 2006;7 (7) 583- 590
PubMed
Albert  PRLemonde  S 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004;10 (6) 575- 593
PubMed
Strobel  AGutknecht  LRothe  CReif  AMossner  RZeng  YBrocke  BLesch  KP Allelic variation in 5-HT1A receptor expression is associated with anxiety- and depression-related personality traits. J Neural Transm 2003;110 (12) 1445- 1453
PubMed
Canli  TZhao  ZDesmond  JEKang  EGross  JGabrieli  JD An fMRI study of personality influences on brain reactivity to emotional stimuli. Behav Neurosci 2001;115 (1) 33- 42
PubMed
Haas  BWOmura  KConstable  RTCanli  T Emotional conflict and neuroticism: personality-dependent activation in the amygdala and subgenual anterior cingulate. Behav Neurosci 2007;121 (2) 249- 256
PubMed
Drago  ARonchi  DDSerretti  A 5-HT1A gene variants and psychiatric disorders: a review of current literature and selection of SNPs for future studies. Int J Neuropsychopharmacol 2008;11 (5) 701- 721
PubMed
Arango  VUnderwood  MDBoldrini  MTamir  HKassir  SAHsiung  SChen  JJMann  JJ Serotonin 1A receptors, serotonin transporter binding and serotonin transporter mRNA expression in the brainstem of depressed suicide victims. Neuropsychopharmacology 2001;25 (6) 892- 903
PubMed
Boldrini  MUnderwood  MDMann  JJArango  V Serotonin-1A autoreceptor binding in the dorsal raphe nucleus of depressed suicides. J Psychiatr Res 2008;42 (6) 433- 442
PubMed
Drevets  WCFrank  EPrice  JCKupfer  DJHolt  DGreer  PJHuang  YGautier  CMathis  C PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 1999;46 (10) 1375- 1387
PubMed
Hirvonen  JKarlsson  HKajander  JLepola  AMarkkula  JRasi-Hakala  HNagren  KSalminen  JKHietala  J Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635. Int J Neuropsychopharmacol 2008;11 (4) 465- 476
PubMed
Lanzenberger  RRMitterhauser  MSpindelegger  CWadsak  WKlein  NMien  LKHolik  AAttarbaschi  TMossaheb  NSacher  JGeiss-Granadia  TKletter  KKasper  STauscher  J Reduced serotonin-1A receptor binding in social anxiety disorder. Biol Psychiatry 2007;61 (9) 1081- 1089
PubMed
Neumeister  ABain  ENugent  ACCarson  REBonne  OLuckenbaugh  DAEckelman  WHerscovitch  PCharney  DSDrevets  WC Reduced serotonin type 1A receptor binding in panic disorder. J Neurosci 2004;24 (3) 589- 591
PubMed
Mayberg  HS Modulating dysfunctional limbic-cortical circuits in depression: towards development of brain-based algorithms for diagnosis and optimised treatment. Br Med Bull 2003;65193- 207
PubMed
Ressler  KJMayberg  HS Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic. Nat Neurosci 2007;10 (9) 1116- 1124
PubMed

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Web of Science® Times Cited: 74

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles